Ostarine, or mk-2866, is a selective androgen receptor modulator, or SARM, developed by GTx with the primary purpose of preventing and treating muscle wasting conditions. SARMS have selective anabolic activity at particular androgen receptors. They do not demonstrate anabolic activity in non-skeletal tissues, as opposed to testosterone and other similar anabolic steroids. Ostarine attaches to the androgen receptor and shows bone and muscular anabolic activity.
The attaching and triggering of the androgen receptor changes the expression of genes and heightens the synthesis of protein which, in turn, builds muscle, which is one reason people buy Ostarine. It acts similar to steroids, but it does not create the growth on prostate or secondary sexual organs. It works almost solely on muscle tissue.
SARMS are just a new class of androgen receptor ligands. Its purpose is to have a similar kind of effect with androgenic drugs such as anabolic steroids but to have a much more selective way of acting. They are used for more various clinical indications than anabolic steroids. Currently existing androgens for hormone replacement therapies in males are usually delivered through skin formulations or injected. Testosterone esters in injectable form, such as propionate and cypionate, generally create unwanted fluxes in testosterone blood levels, with extremely high levels just after injection then extremely low a few moments after.
On the other hand, SARMs give the chance of producing molecules designed to be delivered orally, but with the ability to selectively aim for the androgen receptors in various tissues in different ways. SARMs are likely to demonstrate some virilising effects when used at high doses and at low doses they will be much effective in being selective for anabolic effects, and this is the reason some buy Ostarine and other similar SARMs, such as lgd-4033.
First-generation SARMs that were developed have the advantage of being orally active without triggering any liver damage. This is in contrast to most anabolic steroids which are not orally active and must be injected, and also those anabolic steroids which are orally active but have the tendency of triggering liver damage depending on the dose. Further research is being conducted to produce more selective and effective SARMs, as well as improving characteristics such as increased half-life and oral bio availability. A lot of different global pharmaceutical companies are currently studying, analysing, and testing other prospective SARMs, but those looking for SARMs can buy Ostarine and Andarine.
Compared to steroids, SARMs don’t require injections because they can be taken orally, there is no conversion to Estrogen or conversion to Dihydrotestosterone (DHT), no severe liver toxicity, it does not impede HPTA, all while having similar effects to testosterone such as strength gain, fat loss, and increased lean body mass. SARMs can be used for bulking, cutting, and recomping. It is all just a matter of using and utilizing SARMs the proper way. This can be done by making it act as a bridge in between steroid cycles and by using them in a way that allows for an easier time of adding to gains completed on earlier cycles. Users who buy Ostarine and similar SARMs report feeling better than they normally did on a regular steroid cycle.
In general, though, SARMs are still at an early stage of development, but the potential is seen to be very high. The current known benefits of SARMs include: high oral bioavailability minus any major damage to the liver, being anabolic even at lower doses, being great for strength, gaining lean body mass, body recomposition, enhanced endurance, and having the ability to heal joints. SARMs guarantee the benefits of anabolic supplementation while lessening the unwanted side effects.